438 related articles for article (PubMed ID: 25561237)
1. Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.
Venkatesha SH; Dudics S; Acharya B; Moudgil KD
Int J Mol Sci; 2014 Dec; 16(1):887-906. PubMed ID: 25561237
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
Meroni PL; Valesini G
BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
Popa C; Netea MG; Barrera P; Radstake TR; van Riel PL; Kullberg BJ; Van der Meer JW
Cytokine; 2005 Apr; 30(2):72-7. PubMed ID: 15804598
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.
Kim EY; Moudgil KD
Cytokine; 2017 Oct; 98():87-96. PubMed ID: 28438552
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
8. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
[TBL] [Abstract][Full Text] [Related]
9. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
10. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory molecules: a target for treatment of systemic autoimmune diseases.
Tincani A; Andreoli L; Bazzani C; Bosisio D; Sozzani S
Autoimmun Rev; 2007 Nov; 7(1):1-7. PubMed ID: 17967717
[TBL] [Abstract][Full Text] [Related]
12. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
[TBL] [Abstract][Full Text] [Related]
14. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
[TBL] [Abstract][Full Text] [Related]
15. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.
Amital H; Barak V; Winkler RE; Rubinow A
Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480
[TBL] [Abstract][Full Text] [Related]
16. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
Sebbag M; Parry SL; Brennan FM; Feldmann M
Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
Prud'homme GJ
J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
[TBL] [Abstract][Full Text] [Related]
18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
19. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis.
Taylor PC
Curr Pharm Des; 2003; 9(14):1095-106. PubMed ID: 12769749
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.
Popa C; Barrera P; Joosten LA; van Riel PL; Kullberg BJ; van der Meer JW; Netea MG
Eur Cytokine Netw; 2009 Jun; 20(2):88-93. PubMed ID: 19541595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]